Moreover, expression of HIF-1α and GLUT1 is significantly higher in peripheral blood samples from breast cancer patients than that found in healthy women, a result that points to their expression detection in this biological matrix as a potential diagnostic tool of this disease. The gene discussed is SLC2A1; the disease is breast carcinoma.